1
0
0
(1 - 22 von 27
)
EMPA-Kidney: 'Empa'sizing the role of Flozins in Chronic ...NephJC
www.nephjc.com
— ... Jens Eilbracht , Martina Brueckmann , Martin J Landray, Colin Baigent, Richard Haynes. PMID: Also read: Meta-analysis of all major — ... Jens Eilbracht , Martina Brueckmann , Martin J Landray, Colin Baigent, Richard Haynes. PMID: Also read: Meta-analysis of all major ...
Shinya Goto - My portal - researchmapresearchmap
researchmap.jp
... Katherine R Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes. › sgoto1234
Haneda Mの検索結果 - Bibgraph（ビブグラフ）| PubMedを ...Bibgraph
bibgraph.hpcr.jp
... Jens Eilbracht ,Martina Brueckmann ,Martin J Landray ,Colin Baigent ,Richard Haynes. The New England journal of medicine(N Engl J Med)2023Jan12. メジャー Jens Eilbracht ,Martina Brueckmann ,Martin J Landray ,Colin Baigent ,Richard Haynes. The New England journal of medicine(N Engl J Med)2023Jan12. メジャー ...
Sawako Katoの検索結果 - Bibgraph（ビブグラフ）| PubMedを日本 ...hpcr.jp
bibgraph.hpcr.jp
... ,Katherine R Tuttle ,Dominik Steubl ,Michaela Petrini ,Dan Massey ,Jens Eilbracht ,Martina Brueckmann ,Martin J Landray ,Colin Baigent ,Richard Haynes. › search
Empagliflozin in Patients with Chronic Kidney DiseaseStudocu
www.studocu.com
... Jens Eilbracht, Ph., Martina Brueckmann, M., Martin J. Landray, F.Med., Colin Baigent, F.Med., and Richard Haynes, D. The affiliations of the members of the Jens Eilbracht, Ph., Martina Brueckmann, M., Martin J. Landray, F.Med., Colin Baigent, F.Med., and Richard Haynes, D. The affiliations of the members of the ...
Traduzido Empagliflozin in Patients With Chronic ...Scribd
pt.scribd.com
... Jens Eilbracht, Ph.D., Martina Brueckmann, MD, Martin J. Landray, F.Med. Sci., Colin Baigent, F.Med.Sci., e Richard Haynes, DM As afiliações dos membros do Jens Eilbracht, Ph.D., Martina Brueckmann, MD, Martin J. Landray, F.Med. Sci., Colin Baigent, F.Med.Sci., e Richard Haynes, DM As afiliações dos membros do ...
gfac040.pdf - Oxford AcademicOxford Academic
academic.oup.com
2022 · Zitiert von: 85 — Rajat Deo, Katherine Tuttle, Jens Eilbracht, Stefan Hantel, Mark. Hopley, Martin J. Landray. †. , Colin Baigent. †. , Richard Haynes. †. (. † · Zitiert von: 85 — Rajat Deo, Katherine Tuttle, Jens Eilbracht, Stefan Hantel, Mark. Hopley, Martin J. Landray. †. , Colin Baigent. †. , Richard Haynes. †. (. †.
Design, recruitment, and baseline characteristics of the EMPA ...Clinical Trial Service Unit
www.ctsu.ox.ac.uk
— Rajat Deo, Katherine Tuttle, Jens Eilbracht, Stefan Hantel, Mark. Hopley, Martin J. Landray. †. , Colin Baigent. †. , Richard Haynes. †. (. † — Rajat Deo, Katherine Tuttle, Jens Eilbracht, Stefan Hantel, Mark. Hopley, Martin J. Landray. †. , Colin Baigent. †. , Richard Haynes. †. (. †.
"N Engl J Med"[journal] 检索结果 - 图书馆- 黑龙江中医药大学黑龙江中医药大学
lib.hljucm.net
;Jens Eilbracht.;Martina Brueckmann.;Martin J Landray.;Colin Baigent.;Richard Haynes. 来源: N Engl J Med 年388卷2期 页. 申请馆际互借; 第三方免费 ... ;Jens Eilbracht.;Martina Brueckmann.;Martin J Landray.;Colin Baigent.;Richard Haynes. 来源: N Engl J Med 年388卷2期 页. 申请馆际互借; 第三方免费 ...
Design, recruitment, and baseline characteristics of the ...Altmetric
www.altmetric.com
... Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J Landray, Christoph Wanner, William G Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J Landray, Christoph Wanner, William G ...
Design, recruitment, and baseline characteristics of the EMPA ...Oxford Academic
academic.oup.com
2022 · Zitiert von: 85 — ... Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J. Landray†, Colin Baigent†, Richard Haynes† (†denotes joint senior authors). Writing · Zitiert von: 85 — ... Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J. Landray†, Colin Baigent†, Richard Haynes† (†denotes joint senior authors). Writing ...
Empagliflozin in Patients with Chronic Kidney Disease - ICH GCPichgcp.net
ichgcp.net
... Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes. Abstract. Background: The effects of empagliflozin in patients with Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes. Abstract. Background: The effects of empagliflozin in patients with ...
Empagliflozin in Patients with Chronic Kidney Disease.Providence Digital Commons
digitalcommons.providence.org
... Jens Eilbracht · Martina Brueckmann · Martin J Landray · Colin Baigent · Richard Haynes · The EMPA-KIDNEY Collaborative Group. Document Type. Article Jens Eilbracht · Martina Brueckmann · Martin J Landray · Colin Baigent · Richard Haynes · The EMPA-KIDNEY Collaborative Group. Document Type. Article ...
Empagliflozin in Patients with Chronic Kidney DiseaseAltmetric
www.altmetric.com
... Jens Eilbracht, Martina Brueckmann, Martin J. Landray, Colin Baigent, Richard Haynes [show]. View on publisher site Alert me about new mentions. X Jens Eilbracht, Martina Brueckmann, Martin J. Landray, Colin Baigent, Richard Haynes [show]. View on publisher site Alert me about new mentions. X ...
Empagliflozin in Patients with Chronic Kidney DiseaseElsevier
providence.elsevierpure.com
von EMPA-KIDNEY Collaborative Group · · Zitiert von: 852 — ... Jens Eilbracht and Martina Brueckmann and Landray, {Martin J.} and Colin Baigent and Richard Haynes",. note = "Publisher Copyright: {\textcopyright} von EMPA-KIDNEY Collaborative Group · · Zitiert von: 852 — ... Jens Eilbracht and Martina Brueckmann and Landray, {Martin J.} and Colin Baigent and Richard Haynes",. note = "Publisher Copyright: {\textcopyright}
Empagliflozin in Patients with Chronic Kidney DiseaseUniversità Cattolica del Sacro Cuore
publires.unicatt.it
... Jens Eilbracht, Giuseppe Grandaliano, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes Show 20 more. Show less. Department of Medicine and Jens Eilbracht, Giuseppe Grandaliano, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes Show 20 more. Show less. Department of Medicine and ...
IgA nephropathy: an overview of drug treatments in clinical ...AI Chat for scientific PDFs
typeset.io
Tuttle,Dominik Steubl,Michaela Petrini,Dan Massey,Jens Eilbracht,Martina Brueckmann,Martin J Landray,Colin Baigent,Richard Haynes +37 more Oct Tuttle,Dominik Steubl,Michaela Petrini,Dan Massey,Jens Eilbracht,Martina Brueckmann,Martin J Landray,Colin Baigent,Richard Haynes +37 more Oct
Kidney disease trials for the 21st centuryOUCI
ouci.dntb.gov.ua
... Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J Landray, Christoph Wanner, William G Jens Eilbracht, Stefan Hantel, Mark Hopley, Martin J Landray, Colin Baigent, Richard Haynes, Colin Baigent, Martin J Landray, Christoph Wanner, William G ...
Empagliflozin in Patients with Chronic Kidney Disease,The ...X-Mol
www.x-mol.com
— ... Jens Eilbracht 1 , Martina Brueckmann 1 , Martin J Landray 1 , Colin Baigent 1 , Richard Haynes 1. Affiliation. The affiliations of the — ... Jens Eilbracht 1 , Martina Brueckmann 1 , Martin J Landray 1 , Colin Baigent 1 , Richard Haynes 1. Affiliation. The affiliations of the ...
"N Engl J Med"[journal] 检索结果 - 图书馆- 黑龙江中医药大学hljucm.net
lib.hljucm.net
... R Tuttle.;Dominik Steubl.;Michaela Petrini.;Dan Massey.;Jens Eilbracht.;Martina Brueckmann.;Martin J Landray.;Colin Baigent.;Richard Haynes. › Search
Empagliflozin in Patients with Chronic Kidney Disease. - QxMDQxMD
www.qxmd.com
... Katherine R Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes. › ...
Design, recruitment, and baseline characteristics of the EMPA ...x-mol.com
www.x-mol.com
— ... Katherine Tuttle , Jens Eilbracht , Stefan Hantel , Mark Hopley , Martin J Landray , Colin Baigent , Richard Haynes , Colin Baigent ... › paper
Alle Infos zum Namen "Jens Eilbracht"
sortiert nach Relevanz / Datum